Deblina Raychaudhuri

Author

Indian Institute of Chemical Biology

Also Known As

Deblina Raychaudhuri, Raychaudhuri, Deblina

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Indian Institute of Chemical Biology Academy of Scientific and Innovative Research Council of Scientific and Industrial Research Institute of Post Graduate Medical Education and Research The University of Texas MD Anderson Cancer Center

About

Deblina Raychaudhuri is an author at Indian Institute of Chemical Biology specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	181
2	Cell Biology	2	2	150
3	Immunology	2	2	31
4	Cellular Physiology	1	1	115
5	Pathology	1	1	13

Deblina Raychaudhuri

Publications

743

Citations

H-Index

Page 1

	Year	Citations
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation Chinky Shiu Chen Liu, Deblina Raychaudhuri, Barnali Paul, The Journal of Immunology	2018	160
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells Deblina Raychaudhuri, Roopkatha Bhattacharya, Bishnu Prasad Sinha, Frontiers in Immunology	2019	160
Histone lactylation drives CD8+ T cell metabolism and function Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, Nature Immunology ChromatinChromatin RemodelingEpigenetic ChangeEpigenomicsEpigenetics	2024	115
Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation Amrit Raj Ghosh, Roopkatha Bhattacharya, Shamik Bhattacharya, Diabetes	2016	109
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Nature Communications	2022	40
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Nature Cancer Neuro-oncologyGliomaMyeloid-specific Kdm6b InhibitionImmune Checkpoint InhibitorAnti-cancer Agent	2023	35
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist Ayan Mukherjee, Deblina Raychaudhuri, Bishnu Prasad Sinha, Journal of Medicinal Chemistry	2020	27
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9 Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, Journal of Medicinal Chemistry	2021	23
Activity-guided development of potent and selective toll-like receptor 9 antagonists Barnali Paul, Oindrila Rahaman, Swarnali Roy, European Journal of Medicinal Chemistry InflammationToll-like ReceptorsAnti-inflammatoryActivity-guided DevelopmentMedicine	2018	18
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype Oindrila Rahaman, Roopkatha Bhattacharya, Chinky Shiu Chen Liu, The Journal of Immunology	2019	18

Page 1